← All trials
NCT05675605
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 24, 2023
- Primary completion
- Jun 1, 2025
- Completion date
- Dec 1, 2025
- First posted
- Jan 9, 2023
- Last posted
- Nov 18, 2023
- Enrollment
- 248
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- TYK Medicines, IncLead sponsor
- Jilin UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.